Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors | Zendy

Tiina Vesterinen | Zendy; Helena Leijon | Zendy; Harri Mustonen | Zendy; Satu Maria Remes | Zendy; Aija Knuuttila | Zendy; Kaisa Salmenkivi | Zendy; Paula Vainio | Zendy; Johanna Arola | Zendy; Caj Haglund | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors

Author(s) -

Tiina Vesterinen,

Helena Leijon,

Harri Mustonen,

Satu Maria Remes,

Aija Knuuttila,

Kaisa Salmenkivi,

Paula Vainio,

Johanna Arola,

Caj Haglund

Publication year - 2019

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-01931

Subject(s) - somatostatin receptor , somatostatin receptor 2 , somatostatin receptor 1 , somatostatin , immunohistochemistry , neuroendocrine tumors , medicine , pathology , gastroenterology , oncology , biology

Pulmonary carcinoids (PCs) belong to neuroendocrine tumors that often overexpress somatostatin receptors (SSTRs). This overexpression provides a molecular basis for tumor imaging and treatment with somatostatin analogs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research